I missed the beginning of the most recent CC (and
Post# of 148184
"Due to the lack of patients during the COVID-19 pandemic, the Company is closing down its Phase 2 trial for acute GvHD"
Will they resume at some later date? I thought this was a pretty big indication for LL if it was proven to work?